|By PR Newswire||
|November 14, 2012 01:15 AM EST||
PARSIPPANY, N.J., Nov. 14, 2012 /PRNewswire/ -- Ninety percent of women who suffer from migraines agree that with an increased understanding of the triggers, they can better manage their migraines, according to a survey1 conducted by Novartis Consumer Health, Inc., the makers of Excedrin® Migraine.
That is why today, the makers of Excedrin® Migraine have joined with singer, actress and Broadway star, Jordin Sparks, and well-known Lenox Hill Hospital internist Keri Peterson, MD – both migraine sufferers – to launch, "Managing Migraines: Know Your Triggers. Know Your Treatment," a new education campaign. It's designed to raise awareness of the importance of tracking migraine triggers so sufferers can better manage their migraines.
While certain triggers may increase the risk of a migraine, triggers vary from person to person. According to the women surveyed, 83% said they would like better tools to help them track the triggers that lead to their migraines so that they can better manage attacks.
To help migraine sufferers, Excedrin® Migraine has developed a convenient, new tracking tool, My Migraine Triggers™ App, with a neurologist. Available for free on iTunes, this app allows migraine sufferers to track the causes of their migraines and share them with their physician. Migraine sufferers can chart out a daily log of information into customizable reports to easily understand which activities, foods and beverages are associated with the onset of their headaches
"As they say in my business ... the show must go on. As someone who suffers from migraines, it is important for me to understand my migraine triggers so I can stop my migraines before they stop me," says Sparks. "That's why I'm thrilled to be teaming up with the makers of Excedrin® Migraine to launch this education campaign and help migraine sufferers become better informed about their triggers and symptoms."
"I encourage all my patients who suffer from migraines to download the My Migraine Triggers™ app," says Lenox Hill Hospital internist and migraine sufferer Keri Peterson, MD. "I was shocked to learn that less than half (45%) of female migraine sufferers surveyed regularly share migraine trigger information with their physician. The new My Migraine Triggers™ app has a great feature which enables my patients to send me data about their migraines before they even walk into my office, allowing me to create a better treatment plan."
For more tips on managing migraines visit www.excedrin.com/migraine or find us on www.facebook.com/excedrin or follow Excedrin® on Twitter @excedrin. As with all medications, use Excedrin® Migraine as directed on the package label.
About Excedrin® Migraine
The first non-prescription medicine approved by the FDA to treat all the symptoms of a migraine including, pain, nausea and sensitivity to light and/or sound. Excedrin® Migraine is the #1 Neurologist recommended over-the-counter brand for migraine relief.
About the Survey
This research was conducted between September 7 and September 13, 2012 via an online survey of 1,000 women in the U.S. To qualify for this survey, respondents had to indicate that they experience migraine headaches at least four to six times per year and have a smartphone or tablet device.
KRC Research is a full service market research firm. The organization offers global quantitative and qualitative market research solutions that use proven methodologies, proper sampling techniques, and pull from over 30 years of experience interpreting consumer feedback.
The foregoing release contains forward-looking statements including express or implied discussions regarding potential future sales of Excedrin Migraine. You should not place undue reliance on these statements. Such forward-looking statements reflect the current views of management regarding future events, and involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. There can be no guarantee that Excedrin Migraine will achieve any particular sales levels in the future. In particular, management's expectations could be affected by, among other things, unexpected manufacturing issues; unexpected regulatory actions or delays or government regulation generally; competition in general; the impact that the foregoing factors could have on the values attributed to the Novartis Group's assets and liabilities as recorded in the Group's consolidated balance sheet, and other risks and factors referred to in Novartis AG's current Form 20-F on file with the US Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, believed, estimated or expected. Novartis is providing the information in this press release as of this date and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.
Novartis Consumer Health, Inc. (NCH) is a world leader in the research, development, production and marketing of self-medication products that do not require a prescription. NCH products are designed for the in-home treatment and prevention of medical conditions and ailments as well as the enhancement of overall health and well-being.
Located in Parsippany, New Jersey, Novartis Consumer Health, Inc. is an affiliate of Novartis AG. Novartis provides innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, eye care, cost-saving generic pharmaceuticals, preventive vaccines and diagnostic tools, over-the-counter and animal health products. Novartis is the only global company with leading positions in these areas. In 2011, the Group's continuing operations achieved net sales of USD 58.6 billion, while approximately USD 9.6 billion (USD 9.2 billion excluding impairment and amortization charges) was invested in R&D throughout the Group. Novartis Group companies employ approximately 127,000 full-time-equivalent associates and operate in more than 140 countries around the world. For more information, please visit http://www.novartis.com.
Novartis is on Twitter. Sign up to follow @Novartis at http://twitter.com/novartis.
1. This research was conducted between September 7 and September 13, 2012 via an online survey of 1,000 women in the U.S. To qualify for this survey, respondents had to indicate that they experience migraine headaches at least 4 to 6 times per year and have a smartphone or tablet device.
Novartis Media Relations
+1 212 830 2465 (direct)
+1 862 579 8456 (mobile)
e-mail: [email protected]
Novartis Consumer Health
+1 973 503 7483 (direct)
+1 973 479 2078 (mobile)
SOURCE Novartis Consumer Health, Inc.
@ThingsExpo has been named the Most Influential ‘Smart Cities - IIoT' Account and @BigDataExpo has been named fourteenth by Right Relevance (RR), which provides curated information and intelligence on approximately 50,000 topics. In addition, Right Relevance provides an Insights offering that combines the above Topics and Influencers information with real time conversations to provide actionable intelligence with visualizations to enable decision making. The Insights service is applicable to eve...
Apr. 27, 2017 06:30 PM EDT Reads: 2,813
Building a cross-cloud operational model can be a daunting task. Per-cloud silos are not the answer, but neither is a fully generic abstraction plane that strips out capabilities unique to a particular provider. In his session at 20th Cloud Expo, Chris Wolf, VP & Chief Technology Officer, Global Field & Industry at VMware, will discuss how successful organizations approach cloud operations and management, with insights into where operations should be centralized and when it’s best to decentraliz...
Apr. 27, 2017 06:00 PM EDT Reads: 778
DevOps is often described as a combination of technology and culture. Without both, DevOps isn't complete. However, applying the culture to outdated technology is a recipe for disaster; as response times grow and connections between teams are delayed by technology, the culture will die. A Nutanix Enterprise Cloud has many benefits that provide the needed base for a true DevOps paradigm.
Apr. 27, 2017 06:00 PM EDT Reads: 1,025
Cybersecurity is a critical component of software development in many industries including medical devices. However, code is not always written to be robust or secure from the unknown or the unexpected. This gap can make medical devices susceptible to cybersecurity attacks ranging from compromised personal health information to life-sustaining treatment. In his session at @ThingsExpo, Clark Fortney, Software Engineer at Battelle, will discuss how programming oversight using key methods can incre...
Apr. 27, 2017 05:30 PM EDT Reads: 3,951
The goal of Continuous Testing is to shift testing left to find defects earlier and release software faster. This can be achieved by integrating a set of open source functional and performance testing tools in the early stages of your software delivery lifecycle. There is one process that binds all application delivery stages together into one well-orchestrated machine: Continuous Testing. Continuous Testing is the conveyor belt between the Software Factory and production stages. Artifacts are ...
Apr. 27, 2017 05:15 PM EDT Reads: 1,265
In recent years, containers have taken the world by storm. Companies of all sizes and industries have realized the massive benefits of containers, such as unprecedented mobility, higher hardware utilization, and increased flexibility and agility; however, many containers today are non-persistent. Containers without persistence miss out on many benefits, and in many cases simply pass the responsibility of persistence onto other infrastructure, adding additional complexity.
Apr. 27, 2017 04:30 PM EDT Reads: 2,286
Quickly find the root cause of complex database problems slowing down your applications. Up to 88% of all application performance issues are related to the database. DPA’s unique response time analysis shows you exactly what needs fixing - in four clicks or less. Optimize performance anywhere. Database Performance Analyzer monitors on-premises, on VMware®, and in the Cloud, including Amazon® AWS and Azure™ virtual machines.
Apr. 27, 2017 04:15 PM EDT Reads: 1,965
Most technology leaders, contemporary and from the hardware era, are reshaping their businesses to do software in the hope of capturing value in IoT. Although IoT is relatively new in the market, it has already gone through many promotional terms such as IoE, IoX, SDX, Edge/Fog, Mist Compute, etc. Ultimately, irrespective of the name, it is about deriving value from independent software assets participating in an ecosystem as one comprehensive solution.
Apr. 27, 2017 03:45 PM EDT Reads: 555
SYS-CON Events announced today that Progress, a global leader in application development, has been named “Bronze Sponsor” of SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Enterprises today are rapidly adopting the cloud, while continuing to retain business-critical/sensitive data inside the firewall. This is creating two separate data silos – one inside the firewall and the other outside the firewall. Cloud ISVs oft...
Apr. 27, 2017 03:28 PM EDT Reads: 256
Developers want to create better apps faster. Static clouds are giving way to scalable systems, with dynamic resource allocation and application monitoring. You won't hear that chant from users on any picket line, but helping developers to create better apps faster is the mission of Lee Atchison, principal cloud architect and advocate at New Relic Inc., based in San Francisco. His singular job is to understand and drive the industry in the areas of cloud architecture, microservices, scalability ...
Apr. 27, 2017 03:00 PM EDT Reads: 3,572
SYS-CON Events announced today that CA Technologies has been named "Platinum Sponsor" of SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, New York, and 21st International Cloud Expo, which will take place in November in Silicon Valley, California.
Apr. 27, 2017 02:00 PM EDT Reads: 2,427
The 20th International Cloud Expo has announced that its Call for Papers is open. Cloud Expo, to be held June 6-8, 2017, at the Javits Center in New York City, brings together Cloud Computing, Big Data, Internet of Things, DevOps, Containers, Microservices and WebRTC to one location. With cloud computing driving a higher percentage of enterprise IT budgets every year, it becomes increasingly important to plant your flag in this fast-expanding business opportunity. Submit your speaking proposal ...
Apr. 27, 2017 01:45 PM EDT Reads: 1,299
DevOps is often described as a combination of technology and culture. Without both, DevOps isn't complete. However, applying the culture to outdated technology is a recipe for disaster; as response times grow and connections between teams are delayed by technology, the culture will die. A Nutanix Enterprise Cloud has many benefits that provide the needed base for a true DevOps paradigm. In his Day 3 Keynote at 20th Cloud Expo, Chris Brown, a Solutions Marketing Manager at Nutanix, will explore t...
Apr. 27, 2017 01:30 PM EDT Reads: 789
New competitors, disruptive technologies, and growing expectations are pushing every business to both adopt and deliver new digital services. This ‘Digital Transformation’ demands rapid delivery and continuous iteration of new competitive services via multiple channels, which in turn demands new service delivery techniques – including DevOps. In this power panel at @DevOpsSummit 20th Cloud Expo, moderated by DevOps Conference Co-Chair Andi Mann, panelists will examine how DevOps helps to meet th...
Apr. 27, 2017 01:15 PM EDT Reads: 1,590
SYS-CON Events announced today that Juniper Networks (NYSE: JNPR), an industry leader in automated, scalable and secure networks, will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Juniper Networks challenges the status quo with products, solutions and services that transform the economics of networking. The company co-innovates with customers and partners to deliver automated, scalable and secure network...
Apr. 27, 2017 01:15 PM EDT Reads: 4,952